FSIS Warns About Imported Cooked Duck Blood Curds From China

Regeneron’s Antibody Cocktail To Be Tested In RECOVERY COVID-19 Phase 3 Trial In UK

Regeneron Pharmaceuticals Inc.’s (REGN) investigational anti-viral antibody cocktail, REGN-COV2, is all set to be studied in a phase III trial in patients hospitalized with COVID-19.

In the phase III study, dubbed RECOVERY, the effects of adding REGN-COV2 to the usual standard-of-care will be compared against standard-of-care alone. The study, which will be conducted at 176 hospital sites across the UK, will assess the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation.

The RECOVERY trial is being coordinated by researchers at the University of Oxford, which acts as the sponsor.

REGN-COV2 is currently being studied in two phase II/III clinical trials for the treatment of COVID-19 and in a phase III trial for the prevention of COVID-19 in household contacts of infected individuals.

George Yancopoulos, President and Chief Scientific Officer of Regeneron, said, “REGN-COV2 was specifically designed by Regeneron scientists to target the virus that causes COVID-19. RECOVERY will be the fourth late-stage randomized clinical trial evaluating REGN-COV2 and will add to our knowledge about how this novel antibody cocktail may help hospitalized patients in need.”

This was Apple's first 'iPad.' It failed miserably

San Francisco (CNN Business)A computer that “fits in the palm of your hand” that you can write on “like a notepad” that turns your scribbles into text on the screen. Sound familiar?

That was CNN’s description of Apple’s Newton tablet when it was first unveiled in 1992 at CES, the electronics tradeshow.
Billed as a technology that would revolutionize people’s lives, the Newton struggled for several years before Apple finally killed it off in 1998.

    But many of those technological features underpin a device that today has helped make Apple the world’s most valuable public company, with its market cap exceeding $2 trillion last month — the iPad.
    The iPad pulled in around $6.6 billion in revenue last quarter, accounting for 11% of Apple’s total sales. And all eyes now are on a virtual event scheduled for Tuesday, when the company could potentially announce a new version of its popular tablet.

    The Apple Pencil, a stylus that Apple first launched in 2015 and has since upgraded, is also a modern version of the original Newton’s note-taking digital pen, with much of the same functionality.

      Apple predicted that Newton would trigger a “huge industry that links information and telecommunications” by the early 2000s.
      Given the smartphones and tablets that are now essential to our daily lives, that prediction has definitely come true — but the Newton wasn’t quite the direct catalyst it was touted as.

      Beyond Meat is launching meat-free meatballs in grocery stores

      • Beyond Meat is launching its meatless meatballs in grocery stores nationwide this week.
      • Demand for refrigerated plant-based meatballs has surged 145% in the 52 weeks ended Aug. 9, according to the latest IRI data.
      • Beyond's meatballs are made with pea protein and brown rice.

      Beyond Meat is bringing its meatless meatballs to grocery stores nationwide.

      The company first made meatballs through a partnership with Subway last year, but grocery stores have also been asking for the item, according to a company spokesperson. Demand for refrigerated plant-based meatballs has surged 145% in the 52 weeks ended Aug. 9, according to the latest IRI data. Competitors like Gardein and Kellogg's Morningstar Farms already sell the meat-free meatballs. 

      Starting this week, consumers will be able to buy Beyond Meatballs made with pea protein, brown rice and Italian seasoning. The suggested retail price is $6.99 for a 12 pack.

      This marks Beyond's third new grocery product in the U.S. this year. The company has already released Beyond Breakfast Sausage and a value pack of its beef-free burgers in 2020. Grocery typically accounts for about half of its revenue, although the pandemic has shifted sales in its favor. 

      Shares of Beyond, which has a market value of $8.42 billion, have risen 78% this year as of Friday's close. 


      Gold Futures Edge Higher As Dollar Loses Ground

      Gold prices are modestly higher Monday morning as the dollar extended recent weakness in the Asian session with traders looking ahead to the upcoming monetary policy meeting of the Federal Reserve.

      Higher U.S. futures that indicate a firm start for equities amid renewed optimism about coronavirus vaccine following resumption of stage III trials in the U.K. by AstraZeneca contributed to dollar’s weakness, but likely limited gold’s uptick as well.

      The dollar index, which dropped to 92.99, is currently at 93.04, down 0.32% from Friday’s close.

      Gold futures for December are up $4.20 or 0.22% at $1,952.10 an ounce.

      Silver futures for December are rising $0.184 or 0.7% at $27.050 an ounce, while Copper futures for December are gaining $0.0142 or 0.47% at $3.0537 per pound.

      FSIS Warns About Imported Cooked Duck Blood Curds From China

      The U.S. Department of Agriculture’s Food Safety and Inspection Service has warned about an undetermined amount of imported cooked duck blood curds from China.

      A recall was not requested because FSIS has been unable to contact the importer. The total amount of ineligible product is undetermined because the investigation is ongoing.

      The product about which FSIS has issued a alert is 10.58 OZ. (300g), vacuum-packed packages containing “Cooked Duck Blood Curds, DUCK BLOOD.”

      The cooked duck blood curds product does not identify an eligible establishment number on its packaging and was not presented to FSIS for import re-inspection. FSIS has not received an official inspection certificate issued by the People’s Republic of China to certify this product as eligible. Therefore, this product is ineligible to import into the U.S., making it unfit for human consumption.

      Retailers who have purchased the product are urged not to sell it. Consumers who purchased the product should not consume it and properly discard it.

      There have been no confirmed reports of adverse reactions due to consumption of these products.